Canaccord Boosts PT on Incyte (INCY) to $85; Sees Plenty of Positive Events in 2014

February 13, 2014 12:29 PM

Canaccord Genuity boosts its price target on Incyte (Nasdaq: INCY) from $79 up to $85, while maintaining a Buy rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found